These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 21255644)

  • 1. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
    Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
    Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.
    Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG
    Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
    Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
    Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
    Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
    Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
    Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
    Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained
    Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
    J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.
    Guinez C; Filhoulaud G; Rayah-Benhamed F; Marmier S; Dubuquoy C; Dentin R; Moldes M; Burnol AF; Yang X; Lefebvre T; Girard J; Postic C
    Diabetes; 2011 May; 60(5):1399-413. PubMed ID: 21471514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ac
    Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
    Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.